These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 16753148)

  • 1. Polo-like kinase 1 regulates mitotic arrest after UV irradiation through dephosphorylation of p53 and inducing p53 degradation.
    Chen J; Dai G; Wang YQ; Wang S; Pan FY; Xue B; Zhao DH; Li CJ
    FEBS Lett; 2006 Jun; 580(15):3624-30. PubMed ID: 16753148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation.
    Smith L; Farzan R; Ali S; Buluwela L; Saurin AT; Meek DW
    Sci Rep; 2017 Nov; 7(1):16115. PubMed ID: 29170437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation.
    Yim H; Erikson RL
    Mol Cell Biol; 2009 May; 29(10):2609-21. PubMed ID: 19289504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plk1 phosphorylation of Numb leads to impaired DNA damage response.
    Shao C; Chien SJ; Farah E; Li Z; Ahmad N; Liu X
    Oncogene; 2018 Feb; 37(6):810-820. PubMed ID: 29059161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plk1-mediated phosphorylation of Topors regulates p53 stability.
    Yang X; Li H; Zhou Z; Wang WH; Deng A; Andrisani O; Liu X
    J Biol Chem; 2009 Jul; 284(28):18588-92. PubMed ID: 19473992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotic phosphotyrosine network analysis reveals that tyrosine phosphorylation regulates Polo-like kinase 1 (PLK1).
    Caron D; Byrne DP; Thebault P; Soulet D; Landry CR; Eyers PA; Elowe S
    Sci Signal; 2016 Dec; 9(458):rs14. PubMed ID: 27965426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallization and preliminary X-ray diffraction studies on the human Plk1 Polo-box domain in complex with an unphosphorylated and a phosphorylated target peptide from Cdc25C.
    García-Alvarez B; Ibañez S; Montoya G
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Apr; 62(Pt 4):372-5. PubMed ID: 16582488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availability.
    Burigotto M; Vigorito V; Gliech C; Mattivi A; Ghetti S; Bisio A; Lolli G; Holland AJ; Fava LL
    EMBO Rep; 2023 Dec; 24(12):e57234. PubMed ID: 37888778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP1 and CHK1 coordinate PLK1 enzymatic activity during the DNA damage response to promote homologous recombination-mediated repair.
    Peng B; Shi R; Bian J; Li Y; Wang P; Wang H; Liao J; Zhu WG; Xu X
    Nucleic Acids Res; 2021 Jul; 49(13):7554-7570. PubMed ID: 34197606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Targeting Plk1 and DNMT3a in Advanced Prostate Cancer.
    Zhang Z; Cheng L; Zhang Q; Kong Y; He D; Li K; Rea M; Wang J; Wang R; Liu J; Li Z; Yuan C; Liu E; Fondufe-Mittendorf YN; Li L; Han T; Wang C; Liu X
    Adv Sci (Weinh); 2021 Jul; 8(13):e2101458. PubMed ID: 34051063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling the role of PLK1 in tumorigenesis by revealing the mutational landscape of colorectal and lung cancer with PLK1 mutations.
    Wang S; Gao F; Bi Y; Zhao X; Ou Q; Zhu M; Wu X; Zhang X; Mao K
    J Cell Mol Med; 2024 Jun; 28(12):e18497. PubMed ID: 38887977
    [No Abstract]   [Full Text] [Related]  

  • 12. An order-to-disorder structural switch activates the FoxM1 transcription factor.
    Marceau AH; Brison CM; Nerli S; Arsenault HE; McShan AC; Chen E; Lee HW; Benanti JA; Sgourakis NG; Rubin SM
    Elife; 2019 May; 8():. PubMed ID: 31134895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Different p53 genotypes regulating different phosphorylation sites and subcellular location of CDC25C associated with the formation of polyploid giant cancer cells.
    Liu K; Zheng M; Zhao Q; Zhang K; Li Z; Fu F; Zhang H; Du J; Li Y; Zhang S
    J Exp Clin Cancer Res; 2024 Aug; 43(1):229. PubMed ID: 39154162
    [No Abstract]   [Full Text] [Related]  

  • 14. KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway.
    Zhai M; Miao J; Zhang R; Liu R; Li F; Shen Y; Wang T; Xu X; Gao G; Hu J; He A; Bai J
    J Cancer Res Clin Oncol; 2024 May; 150(5):239. PubMed ID: 38713252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage checkpoint execution and the rules of its disengagement.
    Yam CQX; Lim HH; Surana U
    Front Cell Dev Biol; 2022; 10():1020643. PubMed ID: 36274841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review.
    Liu K; Zheng M; Lu R; Du J; Zhao Q; Li Z; Li Y; Zhang S
    Cancer Cell Int; 2020; 20():213. PubMed ID: 32518522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 modifications: exquisite decorations of the powerful guardian.
    Liu Y; Tavana O; Gu W
    J Mol Cell Biol; 2019 Jul; 11(7):564-577. PubMed ID: 31282934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
    de Cárcer G
    Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30862113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Childhood Sarcoma Models: Drug Efficacy Biomarker Identification and Validation.
    Geier B; Kurmashev D; Kurmasheva RT; Houghton PJ
    Front Oncol; 2015; 5():193. PubMed ID: 26380223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polo-like kinase-1 in DNA damage response.
    Hyun SY; Hwang HI; Jang YJ
    BMB Rep; 2014 May; 47(5):249-55. PubMed ID: 24667170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.